Iraqi Journal of Hematology

REVIEW ARTICLE
Year
: 2020  |  Volume : 9  |  Issue : 2  |  Page : 55--60

Hereditary hemorrhagic telangiectasia: An informative review


Neha Rajpurohit, Piyush Kumar Bharbey, M Jatin, Khayati Moudgil 
 Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Tamil Nadu, India

Correspondence Address:
Dr. Khayati Moudgil
Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu
India

Inherited hemorrhagic telangiectasia (HHT or Osler–Weber–Rendu syndrome) is a hereditary condition characterized by malformations of multiple blood vessels (vascular dysplasia), which may lead to bleeding (hemorrhaging). Chronic nosebleeds are often the first warning, and malformations in various blood vessels can lead to abnormalities in the lungs, brain, spinal cord, and liver. There are a number of therapies available for various aspects of HHT to improve the quality of life and avoid life-threatening complications. Individuals with HHT have an almost average life expectancy. HHT is inherited as a dominant autosomal trait. We have done this review to enlighten the scientific fraternity about HHT. In this review, we have tried to explain about HHT and its related management.


How to cite this article:
Rajpurohit N, Bharbey PK, Jatin M, Moudgil K. Hereditary hemorrhagic telangiectasia: An informative review.Iraqi J Hematol 2020;9:55-60


How to cite this URL:
Rajpurohit N, Bharbey PK, Jatin M, Moudgil K. Hereditary hemorrhagic telangiectasia: An informative review. Iraqi J Hematol [serial online] 2020 [cited 2021 Apr 15 ];9:55-60
Available from: https://www.ijhonline.org/article.asp?issn=2072-8069;year=2020;volume=9;issue=2;spage=55;epage=60;aulast=Rajpurohit;type=0